Navigation Links
Contraceptive use averts 272,000 maternal deaths worldwide
Date:7/10/2012

Contraceptive use likely prevents more than 272,000 maternal deaths from childbirth each year, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health. Researchers further estimate that satisfying the global unmet need for contraception could reduce maternal deaths an additional 30 percent. Their findings were published July 10 by The Lancet as part of a series of articles on family planning.

"Promotion of contraceptive use is an effective primary prevention strategy for reducing maternal mortality in developing countries. Our findings reinforce the need to accelerate access to contraception in countries with a low prevalence of contraceptive use where gains in maternal mortality prevention could be greatest," said the study's lead author, Saifuddin Ahmed, MBBS, PhD, associate professor in the Bloomberg School's departments of Population, Family and Reproductive Health, and Biostatistics. "Vaccination prevents child mortality; contraception prevents maternal mortality."

Effective contraception is estimated to avert nearly 230 million unintended births each year. Worldwide, roughly 358,000 women and 3 million newborn babies die each year because of complications related to pregnancy and childbirth. Nearly all of these deaths occur in developing countries, where 10 to 15 percent of pregnancies end in maternal death due to unsafe abortions.

The Johns Hopkins researchers used a counterfactual modeling approach to replicate the World Health Organization's (WHO) maternal mortality estimation method, and to estimate maternal deaths averted by contraceptive use in 172 countries. Data for the analysis were drawn from the WHO database for maternal mortality estimation, survey data for contraceptive use and information on births, female population aged 15 to 49 years and general fertility rates from the United Nations World Population Prospects database, 2010.

According to the authors, worldwide use of contraception averted 272,000 maternal deaths, or 38 deaths per 100,000 women using contraception. The estimate is equivalent to a 44 percent reduction in maternal deaths worldwide. The decline in deaths for individual countries ranged from 7 percent to as high as 61 percent. The study authors further estimated that in the absence of contraceptive use the number of maternal deaths would be 1.8 times higher for the study period.

"Unwanted fertility and unmet contraceptive need are still high in many developing countries, and women are repeatedly exposed to life-threatening pregnancy complications that could be avoided with access to effective contraception. This study demonstrates how use of contraception is a substantial and effective primary prevention strategy for reducing maternal mortality, especially in low-income countries," said Amy Tsui, PhD, senior author of the study and director of the Bloomberg School's Bill and Melinda Gates Institute for Population and Reproductive Health.

"Maternal deaths averted by contraceptive use: an analysis of 172 countries" was written by Saifuddin Ahmed, Qingfeng Li, Li Liu, and Amy O. Tsui.


'/>"/>
Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Related biology news :

1. Identification of differential proteins in maternal serum with Down syndrome
2. Good news: Fewer maternal and child deaths
3. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
4. Tax on salt could reduce cardiovascular disease deaths by 3 percent
5. "Babolat Play & Connect" - Worldwide Exclusive Event at the French Open
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the full spectrum of drug and device development, and Prism Clinical Research ... and clinicians, today announced Verified Clinical Trials (VCT) has been selected ...
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading producer ... Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 ... form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface ...
Breaking Biology Technology: